Radionetics Oncology Revenue

Pharmaceutical Manufacturing • San Diego, California, United States • 21-50 Employees

Radionetics Oncology revenue & valuation

Annual revenue	$670,000
Revenue per employee	$16,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$2,200,000
Total funding	$159,200,000

Key Contacts at Radionetics Oncology

Scott Struthers

Founder & Chairman

Amy Buono

Executive Director, Human Resources

Meredith Fidler

Senior Director, Clinical Development

Alex Campos

Executive Director, Translational Biology Proteomics

Kristrun Thordis Stardal

Director Clinical Operations

Adam Dapcevic

Senior Director, Controller

Peter Chua

Senior Director, Chemistry

Snezana Milutinovic

Associate Director, Translational Research

Angie Vassar

Sr. Director, Program Leadership And Regulatory Operations

Dalei Shao

Director Project Management

Company overview

Headquarters	San Diego, California, United States
Phone number	+18004826516
Website	radionetics.com
NAICS	3254
Founded	2021
Employees	21-50
Socials

Radionetics Oncology Email Formats

Radionetics Oncology uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@radionetics.com), used 80.6% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@radionetics.com	80.6%
{first name}{last name}	johndoe@radionetics.com	19.4%

About Radionetics Oncology

Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company focused on the discovery and development of novel radiopharmaceuticals for the treatment of a wide range of oncology indications and is poised to capitalize on the increasing demand for novel radiotherapeutics. Radionetics Oncology is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Global Investments and has entered into a strategic agreement with Eli Lilly. Radionetics is advancing a pipeline of first-in-class small molecule radioligands targeting G protein coupled receptors for the treatment of a broad range of cancers, including breast cancer, lung cancer, and other indications of high unmet need.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

Entry

Senior

Employees by Department

Radionetics Oncology has 20 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore Radionetics Oncology's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-09-14	1	$54,200,000
2024-02-03	4	$52,500,000
2023-09-14	4	$52,500,000

Funding Insights

$159,200,000

Total funding amount

$52,500,000

Most recent funding amount

Number of funding rounds

Radionetics Oncology Tech Stack

Discover the technologies and tools that power Radionetics Oncology's digital infrastructure, from frameworks to analytics platforms.

Adobe Fonts

Font scripts

Vue.js

JavaScript frameworks

Node.js

Programming languages

Nuxt.js

JavaScript frameworks

HSTS

Security

GSAP

JavaScript frameworks

core-js

JavaScript libraries

Webpack

Miscellaneous

Netlify

CDN

Unpkg

CDN

Frequently asked questions

Radionetics Oncology is located in San Diego, California, US.

You can reach Radionetics Oncology at +18004826516.

Radionetics Oncology generates an estimated annual revenue of $670,000. This revenue figure reflects the company's market position and business performance in its industry.

Radionetics Oncology has an estimated valuation of $2,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Radionetics Oncology was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Radionetics Oncology has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Radionetics Oncology has raised a total of $159,200,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Radionetics Oncology

Scott Struthers

Founder & Chairman

Amy Buono

Executive Director, Human Resources

Meredith Fidler

Senior Director, Clinical Development

Alex Campos

Executive Director, Translational Biology Proteomics

Kristrun Thordis Stardal

Director Clinical Operations

Adam Dapcevic